US Patent Issued to SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS on Aug. 18 for "Methods for treating nasal polyposis by administering an IL-4R antagonist" (American, French Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,642, issued on Aug. 18, was assigned to SANOFI BIOTECHNOLOGY (Gentilly, France) and REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Methods for treating nasal polyposis by administering an IL-4R antagonist" was invented by Leda Mannent (Paris), Gianluca Pirozzi (Bridgewater, N.J.), Allen Radin (Tarrytown, N.Y.), Namita A. Gandhi (Tarrytown, N.Y.) and Robert Evans (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating nasal polyposis. The methods include administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an...